Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$59.18 - $69.99 $5.05 Million - $5.98 Million
-85,376 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$59.31 - $78.82 $773,105 - $1.03 Million
-13,035 Reduced 13.25%
85,376 $5.98 Million
Q4 2020

Feb 02, 2021

BUY
$50.47 - $66.26 $149,088 - $195,732
2,954 Added 3.09%
98,411 $5.89 Million
Q3 2020

Nov 05, 2020

BUY
$51.97 - $63.0 $208,295 - $252,504
4,008 Added 4.38%
95,457 $5.74 Million
Q2 2020

Aug 12, 2020

BUY
$30.8 - $52.47 $6,160 - $10,494
200 Added 0.22%
91,449 $4.8 Million
Q1 2020

May 12, 2020

SELL
$28.4 - $50.7 $2.2 Million - $3.93 Million
-77,529 Reduced 45.94%
91,249 $3.06 Million
Q4 2019

Jan 27, 2020

BUY
$36.31 - $46.83 $3.08 Million - $3.97 Million
84,873 Added 101.15%
168,778 $7.65 Million
Q3 2019

Oct 31, 2019

BUY
$35.66 - $44.99 $1.14 Million - $1.43 Million
31,838 Added 61.15%
83,905 $3.19 Million
Q2 2019

Aug 15, 2019

SELL
$36.57 - $47.97 $3,071 - $4,029
-84 Reduced 0.16%
52,067 $2.26 Million
Q1 2019

May 03, 2019

SELL
$36.47 - $42.17 $25,529 - $29,519
-700 Reduced 1.32%
52,151 $1.99 Million
Q4 2018

Feb 08, 2019

BUY
$41.31 - $52.16 $97,119 - $122,628
2,351 Added 4.66%
52,851 $2.27 Million
Q3 2018

Nov 13, 2018

SELL
$32.85 - $52.0 $121,545 - $192,400
-3,700 Reduced 6.83%
50,500 $2.48 Million
Q2 2018

Aug 15, 2018

SELL
$27.5 - $39.8 $297,000 - $429,839
-10,800 Reduced 16.62%
54,200 $1.74 Million
Q1 2018

May 11, 2018

SELL
$29.98 - $46.35 $92,938 - $143,685
-3,100 Reduced 4.55%
65,000 $2.03 Million
Q4 2017

Feb 06, 2018

BUY
$31.85 - $46.95 $70,070 - $103,290
2,200 Added 3.34%
68,100 $3.11 Million
Q3 2017

Nov 15, 2017

BUY
$35.7 - $39.5 $2.35 Million - $2.6 Million
65,900
65,900 $2.48 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.